Home/Pipeline/COVAX-19

COVAX-19

COVID-19

Phase 2Active

Key Facts

Indication

COVID-19

Phase

Phase 2

Status

Active

Company

Afrigen Biologics

About Afrigen Biologics

South African biotech delivering affordable vaccines and biosimilars using proprietary biologics platforms.

View full company profile

Therapeutic Areas

Infectious Diseases Oncology Immunology

Other COVID-19 Drugs

Drug	Company	Phase	Status
COVID-19 Severity Prediction Test	Age Labs	Development	Active
PanCytoVir™ (oral probenecid)	TrippBio	Phase 2	Active
ARCoV	Abogen	Approved (EUA)	Commercial/Authorized
OT-101	Sapu BioScience	Clinical Trial (Phase not specified)	Active
COVID-19 Vaccine (Inactivated)	Kangtai Biological Products	Approved	Commercial/Emergency Use
COVID-19 Vaccine (Adenovirus Vector)	Kangtai Biological Products	Approved	Commercial/Emergency Use
Idylla SARS-CoV-2 Test	Biocartis	Approved	CE-IVD
Adjuvanted Cell-Based COVID-19 Vaccine	CSL Seqirus	Marketed	Commercial (region-dependent)
Sequential Dialysis Technique	Halberd	Discovery	Conceptual / Dormant
Amubarvimab + Romlusevimab (BRII-196/BRII-198)	Brii Biosciences	Approved	Commercial (China)
COVID-19 Vaccine Testing (for AstraZeneca)	Advaxia Biologics	Approved	Active
COVID-19 Vaccine Clinical Batches	Advaxia Biologics	Clinical	Active